amikacin has been researched along with Foreign Bodies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen-Bacrie, S; Conrath, J; Drancourt, M; Hoffart, L; Trichet, E | 1 |
| Gualdoni, B; Hansbrough, JF; Kim, S; Roehrborn, AA | 1 |
2 other study(ies) available for amikacin and Foreign Bodies
| Article | Year |
|---|---|
Nocardia transvalensis keratitis: an emerging pathology among travelers returning from Asia.
Topics: Administration, Oral; Administration, Topical; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Communicable Diseases, Emerging; Cornea; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Foreign Bodies; Humans; Incidence; Keratitis; Ketoconazole; Male; Molecular Sequence Data; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Thailand; Young Adult | 2011 |
Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Foreign Bodies; Lipids; Mice; Staphylococcal Infections; Staphylococcus aureus | 1995 |